HLA Correlations with Clinical Phenotypes and Risk of Metabolic Comorbidities in Singapore Chinese Psoriasis Patients

Introduction Psoriasis is a systemic, chronic inflammatory disease that not only afflicts the skin but is also associated with cardiovascular disease and metabolic syndrome. The strongest susceptibility loci for the disease is within the human leukocyte antigen (HLA) complex, though specific HLA all...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Molecular diagnosis & therapy 2019-12, Vol.23 (6), p.751-760
Hauptverfasser: Shen, Meixin, Lim, Soon Wei Daniel, Tan, Eugene S., Oon, Hazel H., Ren, Ee Chee
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Introduction Psoriasis is a systemic, chronic inflammatory disease that not only afflicts the skin but is also associated with cardiovascular disease and metabolic syndrome. The strongest susceptibility loci for the disease is within the human leukocyte antigen (HLA) complex, though specific HLA allelic associations vary between populations. Objective Our objective was to investigate HLA associations with clinical phenotypes of psoriasis and metabolic syndrome in Chinese psoriasis cases. Methods We conducted an observational case–control study in Singapore with a cohort of psoriasis cases consecutively recruited from an outpatient specialist dermatological center ( n  = 120) compared with 130 healthy controls. Results Significant HLA associations with psoriasis were observed with HLA-A*02:07, B*46:01, C*01:02, and C*06:02. The three-locus haplotype of A*02:07-C*01:02-B*46:01 was also significant (odds ratio [OR] 3.07; p  = 9.47 × 10 −5 ). We also observed an association between nail psoriasis and HLA-A*02:07 carriers (OR 4.50; p  = 0.002), whereas C*06:02 carriers were less prone to have nail involvement (OR 0.16; p  = 0.004). HLA-A*02:07 was also identified as a possible risk allele for hypertension (OR 2.90; p 
ISSN:1177-1062
1179-2000
DOI:10.1007/s40291-019-00423-z